SANSERA Q4 FY26 Results Analysis: PAT Surges 107%, EBITDA Margin Hits New High
Cofacto Research
Updated May 21, 2026
2 min read
Positive
SANSERA's Q4 FY26 numbers came in strong, with revenue of Rs. 998.74 Cr (+27.77% YoY) and PAT growth of +107.81% YoY. Here's a quick read of what worked, what to watch, and what management said.
Quick Details| Results date | May 21, 2026 |
|---|
| Quarter | Q4 FY 2025-2026 |
|---|
| Revenue (Q4) | Rs. 998.74 Cr (+27.77% YoY) |
|---|
| PAT (Q4) | Rs. 123.06 Cr (+107.81% YoY) |
|---|
| EBITDA margin | 19.75% (+344 bps YoY) |
|---|
| EPS (Q4) | Rs. 19.51 (+103.87% YoY) |
|---|
| Market cap | Rs. 17,781.76 Cr |
|---|
| CMP | Rs. 2,851.60 |
|---|
Quarter Snapshot
SANSERA delivered strong Q4 with 27.77% revenue growth and 107.81% PAT growth, achieving 19.75% EBITDA margin - the highest quarterly level within 25 bps of its 20% target. The margin expansion of 344 bps YoY demonstrates operating leverage as expenses grew slower than revenue. ADS segment (4.4x YoY growth) is emerging as a new growth driver targeting Rs.500-600 Cr by FY27. While FY26 revenue met guidance (15.95% vs 'high-teen' target), the Q4 momentum and margin trajectory suggest execution is ahead of management's conservative FY27 margin outlook.
Key Investment Insights
Key Positives
- Revenue grew 27.77% YoY to Rs.998.74 Cr in Q4, with FY26 growing 15.95% to Rs.3,497.92 Cr
- EBITDA margin expanded to 19.75% in Q4 (344 bps YoY), the highest quarterly level and within 25 bps of 20% target
- PAT grew 107.81% YoY to Rs.123.06 Cr in Q4; FY26 PAT grew 50.71% to Rs.326.86 Cr
- Operating leverage of 510 bps as expenses grew 22.72% while revenue grew 27.77%
- ADS segment growing 4.4x YoY, targeting Rs.500-600 Cr by FY27
- Finance costs declined 46.10% YoY reflecting debt reduction; interest coverage improved to 16.76x
- International business surged 59.9% YoY with strong Sweden and USA performance
Risk Factors
- Material costs grew 32.85% YoY vs revenue 27.77%, indicating commodity pressure on gross margins
- Working capital investment of Rs.3,280.70 Mn absorbed cash; CFO grew only 2.8% despite 48% PAT growth
- Capex of Rs.512.57 Cr exceeded guidance of Rs.375-400 Cr, indicating aggressive investment phase
- Trade receivables up 38% YoY - monitoring required for collection efficiency
- Current borrowings increased 182% to Rs.361.95 Cr for working capital financing
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings
Login Now